期刊文献+
共找到57,760篇文章
< 1 2 250 >
每页显示 20 50 100
肾结核诊治分析(附52例报告) 被引量:81
1
作者 梁国标 沈寅初 +3 位作者 罗旭 赵兴奇 李栋 陈宗平 《中华泌尿外科杂志》 CAS CSCD 北大核心 2004年第1期15-17,共3页
目的 探讨肾结核的临床表现及诊治方法。 方法 肾结核患者 5 2例 ,临床表现膀胱刺激征 36例 (6 9% ) ,腰痛伴肉眼血尿 10例 (19% ) ,肾绞痛及无痛性肉眼血尿各 6例 (11% )。 5 2例中B超提示肾结核 2 0例 ,单侧肾积水 2 2例 ;4 7例肾... 目的 探讨肾结核的临床表现及诊治方法。 方法 肾结核患者 5 2例 ,临床表现膀胱刺激征 36例 (6 9% ) ,腰痛伴肉眼血尿 10例 (19% ) ,肾绞痛及无痛性肉眼血尿各 6例 (11% )。 5 2例中B超提示肾结核 2 0例 ,单侧肾积水 2 2例 ;4 7例肾图示患肾无功能 31例 ;同期尿AFB和Tb PCR检查38例 ,尿AFB阳性 13例 (34% ) ,尿Tb PCR阳性 2 1例 (5 5 % )。误诊为结石或炎症 2 7例。药物治疗 12例 (2 3% ) ,手术治疗 4 0例 (77% )。 结果  12例药物治疗者均痊愈。 4 0例手术后病理均诊断为肾结核 ,2 3例随访 1.5~ 5 .0年均治愈 ,发生输尿管残端综合征 5例。 结论 尿AFB和Tb PCR检查仍是术前确诊肾结核的主要手段。无功能结核肾切除同时应尽可能切除患侧输尿管。 展开更多
关键词 肾结核 临床表现 肉眼血尿 腰痛 手术治疗 药物治疗 肾积水
原文传递
肾结核281例分析 被引量:69
2
作者 丘少鹏 刘卓炜 +3 位作者 陈俊星 邓春华 郑克立 梅骅 《中华泌尿外科杂志》 CAS CSCD 北大核心 2002年第7期398-400,共3页
目的 探讨临床肾结核的早期诊断和治疗。 方法 回顾性分析 2 81例肾结核患者的临床资料。 结果 膀胱刺激征、血尿和腰痛是最常见的临床症状。尿查抗酸杆菌、聚合酶链反应结核菌 (PCR TB DNA)和血清抗结核特异性抗体 (PPD IgG)检查... 目的 探讨临床肾结核的早期诊断和治疗。 方法 回顾性分析 2 81例肾结核患者的临床资料。 结果 膀胱刺激征、血尿和腰痛是最常见的临床症状。尿查抗酸杆菌、聚合酶链反应结核菌 (PCR TB DNA)和血清抗结核特异性抗体 (PPD IgG)检查阳性率分别为 42 .7%、44 .1%和6 2 .5 % ;IVU、B超、CT的诊断阳性率分别为 6 9.1%、2 8.3%、84.3%。 12 8例药物 (异烟肼 +利福平+吡嗪酰胺三联治疗 ,6~ 8个月 )治疗者中 10 5例获痊愈 ,15 3例手术治疗者中 145例 (94.8% )施行患侧肾输尿管联合切除术。 结论 联合实验室检查可使临床不典型肾结核的诊断阳性率得到较大提高。IVU仍然是肾结核诊断的首选影像学检查 ,CT对可疑病例有一定的辅助诊断价值。早期肾结核短程三联治疗效果满意。肾结核肾切除应尽可能切除患侧输尿管。 展开更多
关键词 肾结核 诊断 治疗 病例分析 B超 CT 诊断
原文传递
终末期肾功能衰竭透析病人的心理问题研究 被引量:66
3
作者 周安琪 季建林 徐俊冕 《中国行为医学科学》 CSCD 1994年第2期73-75,共3页
采用综合性医院焦虑抑郁量表(HAD)、Hamilton抑郁和焦虑量表(HAMD、HAMA),以及日常生活能力量表(ADL)对上海市三所综合性教学医院肾病科住院透析病人进行了透析前后对照研究,同时对这些病人采用CCMD... 采用综合性医院焦虑抑郁量表(HAD)、Hamilton抑郁和焦虑量表(HAMD、HAMA),以及日常生活能力量表(ADL)对上海市三所综合性教学医院肾病科住院透析病人进行了透析前后对照研究,同时对这些病人采用CCMD-2的有关诊断标准进行临床诊断性会谈。结果发现,透析病人有较高的心理障碍罹患率(57.45%),其中透析前病人的心理问题更为多见,抑郁、焦虑症状的罹患率达82.98%。透析后病人的各量表评分均有显著下降(P<0.05),提示透析治疗本身对病人的心理状况有一定的影响。另外,对HAD(自评量表)与HAMA、HAMD(他评量表)进行了一致性分析,发现HAD与后两者之间有较好的相关性(r=0.76和0.82,P<0.05),提示HAD是一个较可靠的量表。 展开更多
关键词 肾功能衰竭 焦虑抑郁量表 透析疗法 心理障碍
下载PDF
Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy 被引量:56
4
作者 Desirée Luis-Rodríguez Alberto Martínez-Castelao +2 位作者 José Luis Górriz Fernando de lvaro Juan F Navarro-González 《World Journal of Diabetes》 SCIE CAS 2012年第1期7-18,共12页
Diabetes mellitus and its complications are becoming one of the most important health problems in the world. Diabetic nephropathy is now the main cause of end-stage renal disease. The mechanisms leading tothe develop... Diabetes mellitus and its complications are becoming one of the most important health problems in the world. Diabetic nephropathy is now the main cause of end-stage renal disease. The mechanisms leading tothe development and progression of renal injury are not well known. Therefore, it is very important to f ind new pathogenic pathways to provide opportunities for early diagnosis and targets for novel treatments. At the present time, we know that activation of innate immunity with development of a chronic low grade inflammatory response is a recognized factor in the pathogenesis of diabetic nephropathy. Numerous experimental and clinical studies have shown the participation of different inflammatory molecules and pathways in the pathophysiology of this complication. 展开更多
关键词 Diabetes DIABETIC NEPHROPATHY INNATE immunity INFLAMMATION renal failure
下载PDF
he Spectrum of Biopsy-Proven Glomerular Disease in China: A Systematic Review 被引量:56
5
作者 Yue Yang Zheng Zhang +2 位作者 Li Zhuo Da-Peng Chen Wen-Ge Li 《Chinese Medical Journal》 SCIE CAS CSCD 2018年第6期731-735,共5页
Background: Chronic kidney disease has become a leading public health concern in China, as it is associated with increased morbidity, mortality, and costs. However, the overall situation regarding common glomerular d... Background: Chronic kidney disease has become a leading public health concern in China, as it is associated with increased morbidity, mortality, and costs. However, the overall situation regarding common glomerular diseases in China remains unclear. Hence, the aim of this study was to assess the national profile of the common types ofglomerulonephritis in China. Methods: We searched Medline, Embase, Cochrane Library, CNKI, SinoMed, VIP, and Wanfang databases for English and Chinese language articles from inception to September 2017. We also collected potentially relevant studies and reviews using a manual search. The fbllowing words in combinations are as keywords: "renal biopsy", "kidney pathological diagnosis", and "spectrum of pathological types". Results: We identified 23 studies involving 176,355 patients from 15 provinces/cities in China. The detection rates of primary glomerulonephritis (PGN) and secondary glomerulonephritis (SGN) were 0.740 and 0.221, respectively. Over the past 30 years, the top five types of PGN were immunoglobulin A nephropathy (IgAN; 24.3%), mesangial proliferative glomerulonephritis (MsPGN; 10.5%), membranous nephropathy (MN; 12.6%), minimal change disease (MCD; 9.8%), and tbcal segmental glomerulosclerosis (FSGS; 4.6%), and the top four types of SGN were lupus nephritis (LN; 8.6%), Henoch-Sch6nlein purpura glomerulonephritis (4.1%), hepatitis B virus-associated glomerulonephritis (HBV-GN; 2.6%), and diabetic nephropathy (DN; 1.6%). The proportion of MN, MCD, HBV-GN, and DN tended to increase, while those of IgAN, MsPGN, FSGS, and LN tended to drop. Conclusions: Although the incidence of SGN is increasing gradually, PGN is still the leading lbrm of kidney disease in patients undergoing renal biopsies in China. IgAN and LN are the most common types of PGN and SGN, respectively. Differences between regions are related to various factors such as nationality, environment, and diet. Furthermore, unified standards and norms 展开更多
关键词 Primary Glomerulus Nephritis renal Biopsy Secondary Glomerulus Nephritis
原文传递
A randomized controlled trial of postoperative tumor lysate-pulsed dendritic cells and cytokine-induced killer cells immunotherapy in patients with localized and locally advanced renal cell carcinoma 被引量:50
6
作者 ZHAN Hai-lun GAO Xin +4 位作者 PU Xiao-yong LI Wei LI Zhi-jian ZHOU Xiang-fu QIU Jian-guang 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第21期3771-3777,共7页
Background It remains a challenge to inhibit the local recurrence or distant metastasis of localized or locally advanced renal cell carcinoma (RCC) after surgical resection. We investigated the feasibility, safety a... Background It remains a challenge to inhibit the local recurrence or distant metastasis of localized or locally advanced renal cell carcinoma (RCC) after surgical resection. We investigated the feasibility, safety and efficacy of immunotherapy using autologous tumor lysate (TL)-pulsed dendritic cells (DCs) and cytokine-induced killer (CIK) cells in patients with localized or locally advanced RCC. 展开更多
关键词 renal cell carcinoma dendritic cells cytokine-induced killer cells immunotherapy
原文传递
Hantavirus infection:a global zoonotic challenge 被引量:50
7
作者 Hong Jiang Xuyang Zheng +3 位作者 Limei Wang Hong Du Pingzhong Wang Xuefan Bai 《Virologica Sinica》 SCIE CAS CSCD 2017年第1期32-43,共12页
Hantaviruses are comprised of tri-segmented negative sense single-stranded RNA, and are members of the Bunyaviridae family. Hantaviruses are distributed worldwide and are important zoonotic pathogens that can have sev... Hantaviruses are comprised of tri-segmented negative sense single-stranded RNA, and are members of the Bunyaviridae family. Hantaviruses are distributed worldwide and are important zoonotic pathogens that can have severe adverse effects in humans. They are naturally maintained in specific reservoir hosts without inducing symptomatic infection. In humans, however,hantaviruses often cause two acute febrile diseases, hemorrhagic fever with renal syndrome(HFRS) and hantavirus cardiopulmonary syndrome(HCPS). In this paper, we review the epidemiology and epizootiology of hantavirus infections worldwide. 展开更多
关键词 HANTAVIRUS Bunyaviridae zoonosis hemorrhagic fever with renal syndrome hantavirus cardiopulmonary syndrome
原文传递
连续性血液净化治疗危重症患者的研究进展 被引量:49
8
作者 盛晓华 汪年松 《中国中西医结合肾病杂志》 2009年第9期838-840,共3页
关键词 连续性血液净化治疗 危重症患者 连续性肾脏替代治疗 间歇性血液透析 重症急性肾衰竭 血液净化技术 renal 肾脏功能
下载PDF
The PI3K/AKT Pathway and Renal Cell Carcinoma 被引量:47
9
作者 Huifang Guo Peter German +8 位作者 Shanshan Bai Sean Barnes Wei Guo Xiangjie Qi Hongxiang Lou Jiyong Liang Eric Jonasch Gordon B.Mills Zhiyong Ding 《Journal of Genetics and Genomics》 SCIE CAS CSCD 2015年第7期343-353,共11页
The phosphatidylinositol 3 kinase (PI3K)/AKT pathway is genetically targeted in more pathway components and in more tumor types than any other growth factor signaling pathway, and thus is frequently activated as a c... The phosphatidylinositol 3 kinase (PI3K)/AKT pathway is genetically targeted in more pathway components and in more tumor types than any other growth factor signaling pathway, and thus is frequently activated as a cancer driver. More importantly, the PI3K/AKT pathway is composed of multiple bifurcating and converging kinase cascades, providing many potential targets for cancer therapy. Renal cell carcinoma (RCC) is a high-risk and high-mortality cancer that is notoriously resistant to traditional chemotherapies or radiotherapies. The PI3K/AKT pathway is modestly mutated but highly activated in RCC, representing a promising drug target. Indeed, PI3K pathway inhibitors of the rapalog family are approved for use in RCC. Recent large-scale integrated analyses of a large number of patients have provided a molecular basis for RCC, reiterating the critical role of the PI3K/AKT pathway in this cancer. In this review, we summarize the genetic alterations of the PI3K/AKT pathway in RCC as indicated in the latest large-scale genome sequencing data, as well as treatments for RCC that target the aberrant activated PI3K/AKT pathway. 展开更多
关键词 PI3K AKT MTOR renal cell carcinoma Targeted therapy
原文传递
高血压病患者肾脏早期损害指标的探讨 被引量:42
10
作者 李招云 吴晓宇 +2 位作者 赖卫强 李素珍 高琳 《中华检验医学杂志》 CAS CSCD 北大核心 2001年第5期282-284,共3页
目的 探讨高血压病患者早期肾脏损害的诊断方法。方法 采用速率散射比浊法检测尿微量白蛋白 (mALB)、β2 微球蛋白 (β2 MG)、全定量酶免疫法测定尿视黄醇结合蛋白 (RBP)、速率法检测N 乙酰 β D 氨基葡萄糖苷酶 (NAG)、Jaffe速率... 目的 探讨高血压病患者早期肾脏损害的诊断方法。方法 采用速率散射比浊法检测尿微量白蛋白 (mALB)、β2 微球蛋白 (β2 MG)、全定量酶免疫法测定尿视黄醇结合蛋白 (RBP)、速率法检测N 乙酰 β D 氨基葡萄糖苷酶 (NAG)、Jaffe速率法测定尿肌酐。 结果 高血压病患者尿RBP、mALB、β2 MG、NAG均较对照组显著增高 (P <0 .0 1) ,并随病期的延长有逐渐增高的趋势。单项及二项检测RBP、mALB、β2 MG、NAG阳性率较低 ,联合其中三项检测阳性率较高 ,联合四项检测阳性率可达85 1% ,RBP与 β2 MG、NAG呈显著正相关 (P <0 .0 5 )。mALB与RBP、β2 MG、NAG无相关性 (P >0 0 5 )。结论 检测尿RBP、mALB、β2 MG、NAG是诊断高血压病早期肾损害的敏感指标 ,联合三至四项指标有较高的检出率 ,对于高血压肾病的早期诊断 。 展开更多
关键词 高血压 视黄A醇结合蛋白 Β2微球蛋白 肾脏损害
原文传递
肾嫌色细胞癌的螺旋CT表现 被引量:42
11
作者 周晓峻 谭华桥 +1 位作者 邓丽萍 章士正 《中华放射学杂志》 CAS CSCD 北大核心 2006年第8期884-886,共3页
肾嫌色细胞癌(chromophobe cell renal carcinoma,CCRC)是一种少见的肾癌亚型,5年生存率在所有的肾癌亚型中最高,因而备受临床、病理学家关注。目前,国内外已有不少有关CCRC的临床病理学文献,但多局限于临床和病理特点的描述,... 肾嫌色细胞癌(chromophobe cell renal carcinoma,CCRC)是一种少见的肾癌亚型,5年生存率在所有的肾癌亚型中最高,因而备受临床、病理学家关注。目前,国内外已有不少有关CCRC的临床病理学文献,但多局限于临床和病理特点的描述,而有关CCRC的影像学表现,迄今为止笔者仅见国外2篇报道。为此,笔者搜集经手术病理证实的CCRC6例,并结合文献探讨其CT表现。 展开更多
关键词 螺旋CT表现 肾嫌色细胞癌 CARCINOMA 临床病理学 CCRC renal 5年生存率 影像学表现 cell 病理学家
原文传递
Update on the treatment of type 2 diabetes mellitus 被引量:41
12
作者 Juan Jose Marin-Penalver Iciar Martin-Timon +1 位作者 Cristina Sevillano-Collantes Francisco Javier del Canizo-Gomez 《World Journal of Diabetes》 SCIE CAS 2016年第17期354-395,共42页
To achieve good metabolic control in diabetes and keep long term, a combination of changes in lifestyle and pharmacological treatment is necessary. Achieving near-normal glycated hemoglobin significantly, decreases ri... To achieve good metabolic control in diabetes and keep long term, a combination of changes in lifestyle and pharmacological treatment is necessary. Achieving near-normal glycated hemoglobin significantly, decreases risk of macrovascular and microvascular complications. At present there are different treatments, both oral and injectable, available for the treatment of type 2 diabetes mellitus(T2DM). Treatment algorithms designed to reduce the development or progression of the complications of diabetes emphasizes the need for good glycaemic control. The aim of this review is to perform an update on the benefits and limitations of different drugs, both current and future, for the treatment of T2 DM. Initial intervention should focus on lifestyle changes. Moreover, changes in lifestyle have proven to be beneficial, but for many patients is a complication keep long term. Physicians should be familiar with the different types of existing drugs for the treatment of diabetes and select the most effective, safe and better tolerated by patients. Metformin remains the first choice of treatment for most patients. Other alternative or second-line treatment options should be individualized depending on the characteristics of each patient. This article reviews the treatments available for patients with T2 DM, with an emphasis on agents introduced within the last decade. 展开更多
关键词 Type 2 diabetes MELLITUS TREATMENT Oral ANTIDIABETIC AGENTS INJECTABLE ANTIDIABETIC AGENTS Older people renal IMPAIRMENT Future treatments
下载PDF
Normoalbuminuric diabetic kidney disease 被引量:41
13
作者 Chao Chen Chang Wang +5 位作者 Chun Hu Yachun Han Li Zhao Xuejing Zhu Li Xiao Lin Sun 《Frontiers of Medicine》 SCIE CAS CSCD 2017年第3期310-318,共9页
Diabetic kidney disease (DKD) is one of the primary causes of end-stage renal disease (ESRD). Early diagnosis is very important in preventing the development of DKD. Urinary albumin excretion rate (UAER) and glo... Diabetic kidney disease (DKD) is one of the primary causes of end-stage renal disease (ESRD). Early diagnosis is very important in preventing the development of DKD. Urinary albumin excretion rate (UAER) and glomerular filtration rate (GFR) are widely accepted as criteria for the diagnosis and clinical grading of DKD, and microalbuminuria has been recommended as the first clinical sign of DKD. The natural history of DKD has been divided into three stages: normoalbuminuria, microalbuminuria, and macroalbuminuria. However, this clinical paradigm has been questioned recently, as studies have shown that a portion of diabetes mellitus (DM) patients with normoalbuminuria have progressive renal insufficiency, referred to as normoalbuminuric diabetic kidney disease (NADKD) or nonalbuminuric diabetic nephropathy. Epidemiologic research has demonstrated that normoalbuminuric diabetic kidney disease is common, and the large number of NADKD patients suggests that the traditional paradigm needs to be shifted. Currently, the pathogenesis of NADKD remains unclear, but many clinical studies have identified some clinical and pathological features of NADKD. In addition, the long-term outcomes of NADKD patients remain controversial. In this article, we reviewed the latest studies addressing the pathogenesis, pathology, treatment and prevention of NADKD. 展开更多
关键词 DIABETES diabetic kidney disease NORMOALBUMINURIA renal impairment
原文传递
Contrast-enhanced ultrasound for detection and diagnosis of renal clear cell carcinoma 被引量:38
14
作者 DONG Xiao-qiu SHEN Yi +3 位作者 XU Li-wei XU Chun-mei BI Wei WANG Xiao-min 《Chinese Medical Journal》 SCIE CAS CSCD 2009年第10期1179-1183,共5页
Background Renal clear cell carcinoma (RCCC) is the most common malignant renal tumor. It is highly malignant, does not cause clinical symptoms in its early stages, and cannot be diagnosed using conventional ultraso... Background Renal clear cell carcinoma (RCCC) is the most common malignant renal tumor. It is highly malignant, does not cause clinical symptoms in its early stages, and cannot be diagnosed using conventional ultrasound. This study was aimed to investigate the contrast-enhanced ultrasound (CEUS) mode and characteristics of the time-intensity curve for RCCC and its pathological basis. Methods Forty-two patients with pathologically diagnosed RCCC underwent CEUS examination before surgery. The patients' kidneys were visualized after injection of contrast agents using the Technos MPX DU8. We analyzed the CEUS mode, time-intensity curve, and pathological findings. Results The detection rate of RCCC with conventional ultrasound was about 71%, while the rate using CEUS was 100%. Larger tumors (33 cases) showed non-uniform enhancement with defective filling. CEUS modes were divided into 4 types: type Ⅰ, "quick in and out" (26.19%, 11/42); type Ⅱ, "quick in and slow out" (40.48%, 17/42); type Ⅲ, "Simultaneous in and out" (16.67%, 7/42); and type Ⅳ "slow in and out" (16.67%, 7/42). All types had a close correlation to the pathological basis. Time-intensity curve of CEUS consisted of 3 phases, the perfusion phase, regression phase, and lag phase. Cases of types Ⅰ and Ⅲ only had a perfusion and regression phase, those of type Ⅱ and Ⅳ had a perfusion phase, regression phase, and lag phase. Quantitative analysis of the time-intensity curve showed that the time-to-peak (FTP) of the lesions was shorter than that of normal renal parenchyma (P 〈0.0001), the mean value of the up slope rate of the absolute value of lesions was higher than that of the ipsilateral normal renal parenchyma (P 〈0.0001), and that the mean value of descent slope rate of the absolute value of lesions was lower than that of the ipsilateral normal renal parenchyma (P 〈0.0001). Conclusions CEUS is useful in detecting small vessels in tumors. Although there are several differen 展开更多
关键词 ULTRASOUND CONTRAST carcinoma renal cell PATHOLOGY
原文传递
540例IgA肾病高血压发生影响因素的分析 被引量:33
15
作者 庄永泽 陈香美 +4 位作者 张燕平 危成筠 石晓云 童新元 张高魁 《中华内科杂志》 CAS CSCD 北大核心 2000年第6期371-375,共5页
目的 探讨影响IgA肾病高血压发生的相关因素。方法 对 5 40例IgA肾病临床病理资料进行回顾性病例对照研究 ,运用单因素及多因素方法分析其高血压发生与临床病理因素的关系。结果 有高血压者 2 14例 ,总发生率 39 6 2 % ,单因素分析... 目的 探讨影响IgA肾病高血压发生的相关因素。方法 对 5 40例IgA肾病临床病理资料进行回顾性病例对照研究 ,运用单因素及多因素方法分析其高血压发生与临床病理因素的关系。结果 有高血压者 2 14例 ,总发生率 39 6 2 % ,单因素分析发现年龄≥ 45岁、男性、高血压家族史、病程≥ 3年、蛋白尿≥ 2 0g/d、血肌酐≥ 133μmol/L、高脂血症、肥胖、系膜增生程度、肾小球硬化率、新月体形成比率、肾小管间质病变及肾小动脉病变程度等为其影响因素。呈单纯血尿者高血压的发生率低。多因素Logistic回归结果显示年龄、高血压家族史、血肌酐水平、蛋白尿程度、血尿程度、体重及肾小动脉病变程度为IgA肾病高血压发生的独立影响因素。结论 IgA肾病是一种进展性肾脏疾病 ,多因素分析结果证实IgA肾病伴高血压的发生与遗传背景、蛋白尿程度、血肌酐水平及肾小动脉病变程度等有关 。 展开更多
关键词 肾小球肾炎 高血压 影响因素 IGA肾病 病理
原文传递
急性肾损伤的诊断及治疗进展 被引量:38
16
作者 梅长林 张彤 《上海医学》 CAS CSCD 北大核心 2009年第3期177-179,共3页
关键词 急性肾损伤 治疗原则 急性肾衰竭 诊断 renal HOMER 生理学 病理学
下载PDF
Epidemiological progresses of hemorhagic fever with renal syndrome in China 被引量:36
17
作者 宋干 《Chinese Medical Journal》 SCIE CAS CSCD 1999年第5期88-93,共6页
Purpose To summarize the major achievements of Chinese work on the epid emiology and prevention of hemorrhagic fever with renal syndrome (HFRS) in recen t years, and to give a general review on the present situation ... Purpose To summarize the major achievements of Chinese work on the epid emiology and prevention of hemorrhagic fever with renal syndrome (HFRS) in recen t years, and to give a general review on the present situation of HFRS in China.Data sources Reviews and papers published in Chinese journals, relevant to the objectives, written or collected by the author; and the research work of the author.Study selection An outline was drafted according to the purpose given a bove, and the relevant materials and data were grouped together into different i tems outlined.Data extraction All the materials and data extracted were published or specially assessed.Results HFRS was first recognized in the northeastern China in 1931. It has been found prevalent also in many other parts of China since 1955, and p resently, 28 out of 31 provinces (autonomous regions, or municipalities) have b een proved to be its endemic areas. The total number of cases is 1?256?431 from 1950 to 1997, with 44?304 death (3.53%). 50-100 thousands of cases co uld be registered annually since 1981 when the presence of the Rattus type HFRS wa s first identified serologically in China, with the highest peak in 1986 ( 115 ?985 cases). Three types of endemicity have been differentiated: the Apodemus type, the Rattus type and the mixed type of the two, by their peculiar season al distributions of cases and by methods of serotyping (HI, MAbs serotyping kits ). The epidemiologic features of the Rattus type HFRS are quite different from that of the Apodemus type. 67 species of vertebrates were found to harbor hanta virus antigen or antibodies, but the chief or primary reservoir hosts are A podemus agrarius and Rattus norveg icus only. Besides the commonly recognized enzootic mode of transmission (via co ntact s with the reservoir rodents or their excreta), mite transmission (including cer tain species of gamasid mites, and chigger mites) has been identified as the po tential vectors and reservoir hosts with HFRS. Vertical transmission 展开更多
关键词 hemorrhagic fever with renal syndrome EPIDEMIOLOGY prog ress
原文传递
Current oncologic applications of radiofrequency ablation therapies 被引量:33
18
作者 Dhruvil R Shah Sari Green +2 位作者 Angelina Elliot John P McGahan Vijay P Khatri 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2013年第4期71-80,共10页
Radiofrequency ablation (RFA) uses high frequency alternating current to heat a volume of tissue around a needle electrode to induce focal coagulative necrosis with minimal injury to surrounding tissues. RFA can be pe... Radiofrequency ablation (RFA) uses high frequency alternating current to heat a volume of tissue around a needle electrode to induce focal coagulative necrosis with minimal injury to surrounding tissues. RFA can be performed via an open, laparoscopic, or image guided percutaneous approach and be performed under general or local anesthesia. Advances in delivery mechanisms, electrode designs, and higher power generators have increased the maximum volume that can be ablated, while maximizing oncological outcomes. In general, RFA is used to control local tumor growth, prevent recurrence, palliate symptoms, and improve survival in a subset of patients that are not candidates for surgical resection. It's equivalence to surgical resection has yet to be proven in large randomized control trials. Currently, the use of RFA has been well described as a primary or adjuvant treatment modality of limited but unresectable hepatocellular carcinoma, liver metastasis, especially colorectal cancer metastases, primary lung tumors, renal cell carcinoma, boney metastasis and osteoid osteomas. The role of RFA in the primary treatment of early stage breast cancer is still evolving. This review will discuss the general features of RFA and outline its role in commonly encountered solid tumors. 展开更多
关键词 RADIOFREQUENCY ablation HEPATOCELLULAR CARCINOMA Colorectal CANCER liver metastasis Lung CANCER renal cell CARCINOMA
下载PDF
Influence of ginsenoside Rg1, a panaxatriol saponin from Panax notoginseng, on renal fibrosis in rats with unilateral ureteral obstruction 被引量:34
19
作者 Xi-sheng XIE Man YANG +4 位作者 Heng-cuang LIU Chuan ZUO Zi LI Yao DENG Jun-ming FAN 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2008年第11期885-894,共10页
Total saponins of Panax notoginseng (PNS) have been shown to ameliorate renal interstitial fibrosis. Ginsenoside Rg 1, a panaxatriol saponin, is one of the major active molecules from PNS. The present study was unde... Total saponins of Panax notoginseng (PNS) have been shown to ameliorate renal interstitial fibrosis. Ginsenoside Rg 1, a panaxatriol saponin, is one of the major active molecules from PNS. The present study was undertaken to investigate the effect of ginsenoside Rgl on renal fibrosis in rats with unilateral ureteral obstruction (UUO). The rats were randomly divided into 3 groups: sham-operation (n=15), UUO (n=15) and UUO with ginsenoside Rgl treatment (n=15, 50 mg per kg body weight, intraperitoneally (i.p.) injected). The rats were sacrificed on Days 7 and 14 after the surgery. Histological examination demonstrated that ginsenoside Rgl significantly inhibited interstitial fibrosis including tubular injury as well as collagen deposition, u-smooth muscle actin (α-SMA) and E-cadherin are two markers of tubular epithelial-myofibroblast transition (TEMT). Interestingly, ginsenoside Rgl notably decreased α-SMA expression and simultaneously enhanced E-cadherin expression. The messenger RNA (mRNA) of transforming growth factor-β1 (TGF-β1), a key mediator to regulate TEMT, in the obstructed kidney increased dramatically, but was found to decrease significantly after administration of ginsenoside Rg 1. Further study showed that ginsenoside Rgl considerably decreased the levels of both active TGF-β1 and phosphorylated Smad2 (pSmad2). Moreover, ginsenoside Rgl substantially suppressed the expression of thrombospondin-1 (TSP-1), a cytokine which can promote the transcription of TGF-β1 mRNA and the activation of latent TGF-β1. These results suggest that ginsenoside Rgl inhibits renal interstitial fibrosis in rats with UUO. The mechanism might be partly related to the blocking of TEMT via suppressing the expression of TSP-1. 展开更多
关键词 Ginsenoside Rgl renal fibrosis Tubular epithelial-myofibroblast transition (TEMT) Thrombospondin-1 (TSP-1) Transforming growth factor-β1 (TGF-β1)
下载PDF
五苓散对肾性高血压大鼠降压作用的实验研究 被引量:30
20
作者 韩宇萍 王宁生 +1 位作者 宓穗卿 刘启德 《中西医结合学报》 CAS 2003年第4期285-288,共4页
目的 观察五苓散提取液对肾性高血压大鼠的实验治疗效果及其对大鼠尿量和血清Na+ 、K+ 、Cl-浓度的影响。方法 建立改进G 2K1C二肾一夹高血压大鼠模型。大鼠随机分为 6组 :假手术组 ,模型组 ,五苓散高剂量组 (80 g/kg) ,五苓散中剂量... 目的 观察五苓散提取液对肾性高血压大鼠的实验治疗效果及其对大鼠尿量和血清Na+ 、K+ 、Cl-浓度的影响。方法 建立改进G 2K1C二肾一夹高血压大鼠模型。大鼠随机分为 6组 :假手术组 ,模型组 ,五苓散高剂量组 (80 g/kg) ,五苓散中剂量组 (40g/kg) ,五苓散低剂量组 (2 0 g/kg) ,氢氯噻嗪组 (2 5mg/kg)。灌胃给药期间测量大鼠尿量 ,给药 30d后测定大鼠尾动脉压 ,并取血测定血清Na+ 、K+ 、Cl-浓度。结果 五苓散高、中、低剂量组均能降低肾性高血压大鼠的血压 (P <0 .0 5或P <0 .0 1) ,但仍高于假手术组 (P <0 .0 1) ,而与氢氯噻嗪组比较无显著差异 (P >0 .0 5 )。五苓散高、中、低剂量组对大鼠有显著利尿作用 (P <0 .0 5或P <0 .0 1) ,但作用较氢氯噻嗪缓和 (P <0 .0 5或P <0 .0 1)。五苓散高、中、低剂量组和氢氯噻嗪组对Na+ 、Cl-浓度均无影响 (P >0 .0 5 ) ,氢氯噻嗪组大鼠血K+ 浓度降低 ,与假手术组及高、中、低剂量组比较有显著差异 (P <0 .0 1)。结论 五苓散提取液对肾性高血压大鼠具有利尿、降压作用 。 展开更多
关键词 五苓散 肾性高血压 大鼠 降压作用 治疗 心血管病 手术
下载PDF
上一页 1 2 250 下一页 到第
使用帮助 返回顶部